Addressing these methodological limitations in future research, such as by improved fixation training protocols and robust participant retention strategies, will be crucial in optimising clinical trial designs and improving outcomes for patients with CRB1-associated retinopathies. This evidence concerns the gene CRB1 and retinal disorder.